Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.38
Delayed Data
As of Apr 20
 +0.34 / +4.83%
Today’s Change
6.15
Today|||52-Week Range
11.34
-18.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$103.3M

Company Description

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in Jerusalem, Israel.

Contact Information

Oramed Pharmaceuticals, Inc.
Hi-Tech Park 2/4
Jerusalem Jerusalem 91390
P:(722) 566-0001
Investor Relations:

Employees

Shareholders

Individual stakeholders22.85%
Other institutional2.61%
Mutual fund holders0.34%

Top Executives

Nadav KidronPresident, Chief Executive Officer & Director
Joshua HexterChief Operating Officer & VP-Business Development
Hilla EisenbergChief Financial Officer, Secretary & Treasurer
Miriam KidronDirector, Chief Medical & Scientific Officer
Ronald LawChief Strategy Officer